Drugs / FloraBaby
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT03266315 | Dec 2022 → Jul 2024 | digestive system disorder | University of Calgary | Terminated | No outcome recorded Stop: Business |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | FloraBaby | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03266315 ↗ |
| Route | Oral | “Probiotics or placebo will be administered orally or via naso- or orogastric feeding tube.” NCT03266315 ↗ |